Explore the Potential with AI-Driven Innovation
The specialised, focused library is developed on demand with the most recent virtual screening and parameter assessment technology, guided by the Receptor.AI drug discovery platform. This approach exceeds the capabilities of traditional methods and offers compounds with higher activity, selectivity, and safety.
From a virtual chemical space containing more than 60 billion molecules, we precisely choose certain compounds. Our collaborator, Reaxense, aids in their synthesis and provision.
In the library, a selection of top modulators is provided, each marked with 38 ADME-Tox and 32 parameters related to physicochemical properties and drug-likeness. Also, every compound comes with its best docking poses, affinity scores, and activity scores, providing a comprehensive overview.
We use our state-of-the-art dedicated workflow for designing focused libraries for enzymes.
Fig. 1. The sreening workflow of Receptor.AI
It includes comprehensive molecular simulations of the catalytic and allosteric binding pockets and the ensemble virtual screening accounting for their conformational mobility. In the case of designing modulators, the structural changes induced by reaction intermediates are taken into account to leverage activity and selectivity.
Key features that set our library apart include:
partner
Reaxense
upacc
Q8NFV4
UPID:
ABHDB_HUMAN
Alternative names:
Alpha/beta hydrolase domain-containing protein 11; Williams-Beuren syndrome chromosomal region 21 protein
Alternative UPACC:
Q8NFV4; H7BYM8; Q6PJU0; Q8N722; Q8N723; Q8NFV2; Q8NFV3; Q9HBS8
Background:
Protein ABHD11, also known as Alpha/beta hydrolase domain-containing protein 11 and Williams-Beuren syndrome chromosomal region 21 protein, plays a crucial role in cellular processes. Its unique structure, characterized by the alpha/beta hydrolase fold, is essential for its diverse functions in the cell.
Therapeutic significance:
Understanding the role of Protein ABHD11 could open doors to potential therapeutic strategies. Its involvement in key cellular mechanisms makes it a promising target for drug discovery, aiming to modulate its activity for therapeutic benefits.